In a first, 5 Indian pharma majors ally for Covid drug trials

In a first, five Indian pharma majors have joined hands to conduct phase-III clinical trials of investigational anti-viral drug Molnupiravir on mild Covid-19 patients. The companies include Dr Reddy's Laboratories Ltd, Cipla Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Emcure Pharmaceuticals Ltd.

from Times of India https://timesofindia.indiatimes.com/india/in-a-first-5-indian-pharma-majors-ally-for-covid-drug-trials/articleshow/83973128.cms